Immunomodulator therapy advances the management of gout
A review of the practical and clinical implications of the MIRROR study and consider the impact of pegloticase combined with an immunomodulator.
Friday 5 from Rheumatology Network – May 14
The Friday 5 from Rheumatology Network is a list composed by the Rheumatology Network editorial staff aimed at highlighting relevant coverage of the latest news in rheumatology.
Friday 5 from Rheumatology Network - April 30
2 Clarke Drive Cranbury, NJ 08512